Published in J Cataract Refract Surg on May 01, 2008
Corneal Crosslinking in Patients With Keratoconus and Post-Refractive Ectasia | NCT01143389
Assessment of Corneal Endothelium After Collagen Cross Linking (CXL) | NCT04160338
UVA-riboflavin photochemical therapy of bacterial keratitis: a pilot study. Graefes Arch Clin Exp Ophthalmol (2011) 2.57
Corneal collagen cross-linking with riboflavin and ultraviolet - a light for keratoconus: results in Indian eyes. Indian J Ophthalmol (2009) 2.12
Brillouin microscopy of collagen crosslinking: noncontact depth-dependent analysis of corneal elastic modulus. Invest Ophthalmol Vis Sci (2013) 1.72
Evaluation of antibacterial efficacy of photo-activated riboflavin using ultraviolet light (UVA). Graefes Arch Clin Exp Ophthalmol (2009) 1.53
A review of collagen cross-linking in cornea and sclera. J Ophthalmol (2015) 1.45
Mechanisms of corneal tissue cross-linking in response to treatment with topical riboflavin and long-wavelength ultraviolet radiation (UVA). Invest Ophthalmol Vis Sci (2009) 1.41
Keratoconus: current perspectives. Clin Ophthalmol (2013) 1.28
SD-OCT analysis of regional epithelial thickness profiles in keratoconus, postoperative corneal ectasia, and normal eyes. J Refract Surg (2013) 1.24
Comparison of Placido disc and Scheimpflug image-derived topography-guided excimer laser surface normalization combined with higher fluence CXL: the Athens Protocol, in progressive keratoconus. Clin Ophthalmol (2013) 1.14
Transepithelial corneal collagen cross-linking in ultrathin keratoconic corneas. Clin Ophthalmol (2012) 1.12
Factors affecting outcomes of corneal collagen crosslinking treatment. Eye (Lond) (2013) 1.10
Patient-specific computational modeling of keratoconus progression and differential responses to collagen cross-linking. Invest Ophthalmol Vis Sci (2011) 1.07
The effect of riboflavin/UVA collagen cross-linking therapy on the structure and hydrodynamic behaviour of the ungulate and rabbit corneal stroma. PLoS One (2013) 1.07
Complications of corneal collagen cross-linking. J Ophthalmol (2011) 1.06
Initial studies using aliphatic beta-nitro alcohols for therapeutic corneal cross-linking. Invest Ophthalmol Vis Sci (2008) 1.04
Corneal collagen cross-linking using riboflavin and ultraviolet-A irradiation: a review of clinical and experimental studies. Int Ophthalmol (2011) 1.03
Quantitative assessment of UVA-riboflavin corneal cross-linking using nonlinear optical microscopy. Invest Ophthalmol Vis Sci (2011) 1.02
Corneal Crosslinking for Keratoconus in Iranian Patients: Outcomes at 1 year following treatment. Middle East Afr J Ophthalmol (2010) 1.02
Pulsed vs continuous light accelerated corneal collagen crosslinking: in vivo qualitative investigation by confocal microscopy and corneal OCT. Eye (Lond) (2014) 1.02
Transforming growth factor-β signaling pathway activation in Keratoconus. Am J Ophthalmol (2011) 1.00
Corneal collagen cross-linking: a review. J Optom (2014) 0.98
Distribution of Young's modulus in porcine corneas after riboflavin/UVA-induced collagen cross-linking as measured by atomic force microscopy. PLoS One (2014) 0.95
Keratoconus: overview and update on treatment. Middle East Afr J Ophthalmol (2010) 0.93
Age-Related Long-Term Functional Results after Riboflavin UV A Corneal Cross-Linking. J Ophthalmol (2011) 0.93
Long-term results of corneal collagen crosslinking for progressive keratoconus. J Optom (2014) 0.93
[Evaluation and quality assurance of refractive surgery procedures by the German Ophthalmological Society and the Professional Association of German Ophthalmologists. Status: May 2011]. Ophthalmologe (2011) 0.93
Biomechanical properties of human corneas following low- and high-intensity collagen cross-linking determined with scanning acoustic microscopy. Invest Ophthalmol Vis Sci (2013) 0.92
The Biomechanical Effect of Corneal Collagen Cross-Linking (CXL) With Riboflavin and UV-A is Oxygen Dependent. Transl Vis Sci Technol (2013) 0.92
Short-term Outcomes of Collagen Crosslinking for Early Keratoconus. J Ophthalmic Vis Res (2011) 0.92
Long-term results of collagen crosslinking with riboflavin and UVA in keratoconus. J Cataract Refract Surg (2008) 0.90
New clinical pathways for keratoconus. Eye (Lond) (2012) 0.90
Standard versus trans-epithelial collagen cross-linking in keratoconus patients suitable for standard collagen cross-linking. Clin Ophthalmol (2015) 0.90
An in vitro intact globe expansion method for evaluation of cross-linking treatments. Invest Ophthalmol Vis Sci (2010) 0.89
Collagen cross-linking: current status and future directions. J Ophthalmol (2012) 0.89
Structural response of human corneal and scleral tissues to collagen cross-linking treatment with riboflavin and ultraviolet A light. Lasers Med Sci (2012) 0.88
Epithelium-on corneal cross-linking treatment of progressive keratoconus: a prospective, consecutive study. Clin Ophthalmol (2014) 0.88
Cost effectiveness of collagen crosslinking for progressive keratoconus in the UK NHS. Eye (Lond) (2015) 0.88
Safety and efficacy of epithelium removal and transepithelial corneal collagen crosslinking for keratoconus. Eye (Lond) (2014) 0.87
[Corneal melting in both eyes after simultaneous corneal cross-linking in a patient with keratoconus and Down syndrome]. Ophthalmologe (2010) 0.87
The genetic and environmental factors for keratoconus. Biomed Res Int (2015) 0.86
Corneal collagen crosslinking in keratoconus and other eye disease. Int J Ophthalmol (2015) 0.85
[Corneal cross-linking with hypo-osmolar riboflavin solution for keratoconus with thin corneas]. Ophthalmologe (2011) 0.85
One-year outcomes of conventional and accelerated collagen crosslinking in progressive keratoconus. Sci Rep (2015) 0.85
Pulsed Light Accelerated Crosslinking versus Continuous Light Accelerated Crosslinking: One-Year Results. J Ophthalmol (2014) 0.84
Management of pediatric keratoconus - evolving role of corneal collagen cross-linking: an update. Indian J Ophthalmol (2013) 0.84
Corneal collagen cross-linking in keratoconus: a systematic review and meta-analysis. Sci Rep (2014) 0.84
[Collagen crosslinking with riboflavin and UVA-light in keratoconus]. Ophthalmologe (2008) 0.84
Corneal biomechanical properties in eyes with no previous surgery, with previous penetrating keratoplasty and with deep anterior lamellar keratoplasty. Jpn J Ophthalmol (2012) 0.84
Long-term results of cornea collagen cross-linking with riboflavin for keratoconus. Indian J Ophthalmol (2013) 0.84
Corneal haze and visual outcome after collagen crosslinking for keratoconus: A comparison between total epithelium off and partial epithelial removal methods. Adv Biomed Res (2014) 0.84
Corneal collagen cross-linking with and without epithelial removal: a contralateral study with 0.5% hypotonic riboflavin solution. Biomed Res Int (2014) 0.84
Theoretical basis, laboratory evidence, and clinical research of chemical surgery of the cornea: cross-linking. J Ophthalmol (2014) 0.83
Topographic corneal changes after collagen cross-linking in patients with corneal keratoconus. J Res Med Sci (2013) 0.83
Imaging mass spectrometry by matrix-assisted laser desorption/ionization and stress-strain measurements in iontophoresis transepithelial corneal collagen cross-linking. Biomed Res Int (2014) 0.82
Comparison of anterior segment measurements using rotating Scheimpflug imaging and partial coherence interferometry. Int J Ophthalmol (2013) 0.82
Collagen crosslinking for keratoconus. J Ophthalmic Vis Res (2011) 0.82
Newer protocols and future in collagen cross-linking. Indian J Ophthalmol (2013) 0.82
Assessment of the tomographic values in keratoconic eyes after collagen crosslinking procedure. Med Arch (2015) 0.82
Corneal cross-linking treatment of keratoconus. Oman J Ophthalmol (2015) 0.81
Prospective, randomized, double-blind trial to investigate the efficacy and safety of corneal cross-linking to halt the progression of keratoconus. BMC Ophthalmol (2015) 0.81
Cosmetic preservatives as therapeutic corneal and scleral tissue cross-linking agents. Invest Ophthalmol Vis Sci (2015) 0.81
Role of corneal epithelium in riboflavin/ultraviolet-A mediated corneal cross-linking treatment in rabbit eyes. Biomed Res Int (2013) 0.81
Alterations of tear mediators in patients with keratoconus after corneal crosslinking associate with corneal changes. PLoS One (2013) 0.81
Collagen cross-linking using riboflavin and ultraviolet-a for corneal thinning disorders: an evidence-based analysis. Ont Health Technol Assess Ser (2011) 0.81
Visual rehabilitation in low-moderate keratoconus: intracorneal ring segment implantation followed by same-day topography-guided photorefractive keratectomy and collagen cross linking. Int J Ophthalmol (2014) 0.80
Transepithelial photorefractive keratectomy with crosslinking for keratoconus. Open Ophthalmol J (2013) 0.80
Methicillin-Resistant Staphylococcus aureus Ocular Infection after Corneal Cross-Linking for Keratoconus: Potential Association with Atopic Dermatitis. Case Rep Ophthalmol Med (2015) 0.79
Pediatric keratoconus and iontophoretic corneal crosslinking: refractive and topographic evidence in patients underwent general and topical anesthesia, 18 months of follow-up. Int Ophthalmol (2015) 0.79
Comparison of clinical results of two pharmaceutical products of riboflavin in corneal collagen cross-linking for keratoconus. Daru (2014) 0.79
Keratoconus: tissue engineering and biomaterials. J Funct Biomater (2014) 0.79
Cross-linking with ultraviolet-a and riboflavin reduces corneal permeability. Invest Ophthalmol Vis Sci (2011) 0.79
Evaluation of the efficacy of excimer laser ablation of cross-linked porcine cornea. PLoS One (2012) 0.79
Hyperopic correction: clinical validation with epithelium-on and epithelium-off protocols, using variable fluence and topographically customized collagen corneal crosslinking. Clin Ophthalmol (2014) 0.79
Clinical outcomes after complete intracorneal ring implantation and corneal collagen cross-linking in an intrastromal pocket in one session for keratoconus. J Ophthalmol (2014) 0.79
Keratoconus corneal architecture after riboflavin/ultraviolet A cross-linking: ultrastructural studies. Mol Vis (2013) 0.79
Corneal collagen cross-linking (CXL) in thin corneas. Eye Vis (Lond) (2015) 0.79
Clinical Outcomes of Small Incision Lenticule Extraction with Accelerated Cross-Linking (ReLEx SMILE Xtra) in Patients with Thin Corneas and Borderline Topography. J Ophthalmol (2015) 0.79
Changes in corneal topography and biomechanical properties after collagen cross linking for keratoconus: 1-year results. Middle East Afr J Ophthalmol (2015) 0.78
Collagen cross-linking in keratoconus in Asian eyes: visual, refractive and confocal microscopy outcomes in a prospective randomized controlled trial. Int Ophthalmol (2015) 0.78
Nonlinear optical collagen cross-linking and mechanical stiffening: a possible photodynamic therapeutic approach to treating corneal ectasia. J Biomed Opt (2013) 0.78
Corneal biomechanical changes after crosslinking for progressive keratoconus with the corneal visualization scheimpflug technology. J Ophthalmol (2014) 0.78
Visual recovery after corneal crosslinking for keratoconus: a 1-year follow-up study. Graefes Arch Clin Exp Ophthalmol (2012) 0.78
Corneal Collagen Cross Linking - PLUS. Open Ophthalmol J (2011) 0.78
Outcome of corneal collagen crosslinking for progressive keratoconus in paediatric patients. Biomed Res Int (2014) 0.78
Fast segmentation of anterior segment optical coherence tomography images using graph cut. Eye Vis (Lond) (2015) 0.78
In vitro effect of corneal collagen cross-linking on corneal hydration properties and stiffness. Graefes Arch Clin Exp Ophthalmol (2012) 0.78
Update on corneal cross-linking for keratoconus. Oman J Ophthalmol (2013) 0.78
PACK-CXL: Corneal Cross-linking for Treatment of Infectious Keratitis. J Ophthalmic Vis Res (2015) 0.78
A study of stromal riboflavin absorption in ex vivo porcine corneas using new and existing delivery protocols for corneal cross-linking. Acta Ophthalmol (2015) 0.78
Corneal changes following collagen cross linking and simultaneous topography guided photoablation with collagen cross linking for keratoconus. Indian J Ophthalmol (2014) 0.78
Corneal Collagen Cross-Linking in the Treatment of Progressive Keratoconus: A Randomized Controlled Contralateral Eye Study. Middle East Afr J Ophthalmol (2015) 0.77
PACK-CXL: Corneal cross-linking in infectious keratitis. Eye Vis (Lond) (2016) 0.77
Scleral cross-linking by riboflavin and blue light application in young rabbits: damage threshold and eye growth inhibition. Graefes Arch Clin Exp Ophthalmol (2015) 0.77
Effects and adverse events after CXL for keratoconus are independent of age: a 1-year follow-up study. Eye (Lond) (2014) 0.77
Current review and a simplified "five-point management algorithm" for keratoconus. Indian J Ophthalmol (2015) 0.77
Biomechanical changes after repeated collagen cross-linking on human corneas assessed in vitro using scanning acoustic microscopy. Invest Ophthalmol Vis Sci (2014) 0.77
Corneal collagen cross-linking for keratoconus and post-LASIK ectasia. Int Ophthalmol Clin (2013) 0.77
Acoustic radiation force for noninvasive evaluation of corneal biomechanical changes induced by cross-linking therapy. J Ultrasound Med (2014) 0.76
Corneal endothelial loss after crosslinking with riboflavin and ultraviolet-A. Graefes Arch Clin Exp Ophthalmol (2012) 0.76
Corneal collagen cross-linking with hypoosmolar riboflavin solution in keratoconic corneas. Biomed Res Int (2014) 0.76
Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol (2003) 8.29
Stress-strain measurements of human and porcine corneas after riboflavin-ultraviolet-A-induced cross-linking. J Cataract Refract Surg (2003) 3.74
Biomechanical evidence of the distribution of cross-links in corneas treated with riboflavin and ultraviolet A light. J Cataract Refract Surg (2006) 2.44
Collagen fiber diameter in the rabbit cornea after collagen crosslinking by riboflavin/UVA. Cornea (2004) 2.15
Effect of central corneal thickness, corneal curvature, and axial length on applanation tonometry. Arch Ophthalmol (2006) 1.87
Endothelial cell damage after riboflavin-ultraviolet-A treatment in the rabbit. J Cataract Refract Surg (2003) 1.82
Keratocyte apoptosis after corneal collagen cross-linking using riboflavin/UVA treatment. Cornea (2004) 1.59
Diurnal fluctuation of higher order ocular aberrations: correlation with intraocular pressure and corneal thickness. J Refract Surg (2004) 1.43
The efficacy of corneal cross-linking shows a sudden decrease with very high intensity UV light and short treatment time. Invest Ophthalmol Vis Sci (2013) 1.43
Dynamic contour tonometry in comparison to intracameral IOP measurements. Invest Ophthalmol Vis Sci (2008) 1.41
Collagen crosslinking of human and porcine sclera. J Cataract Refract Surg (2004) 1.37
Efficacy and safety of tafluprost 0.0015% versus latanoprost 0.005% eye drops in open-angle glaucoma and ocular hypertension: 24-month results of a randomized, double-masked phase III study. Acta Ophthalmol (2010) 1.33
Corneal cross-linking with hypo-osmolar riboflavin solution in thin keratoconic corneas. Am J Ophthalmol (2011) 1.24
Pharmacological modification of the epithelial permeability by benzalkonium chloride in UVA/Riboflavin corneal collagen cross-linking. Curr Eye Res (2010) 1.22
Identification of biomechanical properties of the cornea: the ocular response analyzer. Curr Eye Res (2012) 1.18
Permanent corneal haze after riboflavin-UVA-induced cross-linking in keratoconus. J Refract Surg (2009) 1.16
Persistent corneal edema after collagen cross-linking for keratoconus. Am J Ophthalmol (2013) 1.07
The influence of various substances on the biomechanical behavior of lamina cribrosa and peripapillary sclera. Invest Ophthalmol Vis Sci (2005) 1.07
Detection of biomechanical changes after corneal cross-linking using Ocular Response Analyzer software. J Refract Surg (2011) 1.07
Laboratory measurement of the absorption coefficient of riboflavin for ultraviolet light (365 nm). J Refract Surg (2010) 1.06
Corneal crosslinking with riboflavin and ultraviolet A. Part II. Clinical indications and results. Ocul Surf (2013) 1.05
Riboflavin osmolar modification for transepithelial corneal cross-linking. Curr Eye Res (2012) 1.03
Corneal crosslinking with riboflavin and ultraviolet A. I. Principles. Ocul Surf (2013) 0.99
A correction formula for the real intraocular pressure after LASIK for the correction of myopic astigmatism. J Refract Surg (2006) 0.96
Biomechanical characteristics of retina. Retina (2004) 0.95
Enhanced pressure in the central retinal vein decreases the perfusion pressure in the prelaminar region of the optic nerve head. Invest Ophthalmol Vis Sci (2013) 0.93
Influence of indocyanine green staining on the biomechanical strength of porcine internal limiting membrane. Ophthalmologica (2004) 0.93
Effect of diabetes mellitus on corneal biomechanics and measurement of intraocular pressure. Acta Ophthalmol (2012) 0.92
Oestrogen-induced changes in biomechanics in the cornea as a possible reason for keratectasia. Br J Ophthalmol (2007) 0.92
Corneal cross-linking and safety issues. Open Ophthalmol J (2011) 0.92
Short-term effect of topical antiglaucoma medication on tear-film stability, tear secretion, and corneal sensitivity in healthy subjects. Clin Ophthalmol (2011) 0.90
Correlation between UV absorption and riboflavin concentration in different depths of the cornea in CXL. Curr Eye Res (2010) 0.90
The effect of caffeine on retinal vessel diameter in young healthy subjects. Acta Ophthalmol (2012) 0.89
Absorption of UV-light by riboflavin solutions with different concentration. J Refract Surg (2012) 0.87
Cigarette smoking is negatively associated with keratoconus. J Refract Surg (2008) 0.86
Morphological and functional differences between normal-tension and high-tension glaucoma. Acta Ophthalmol (2013) 0.84
Efficacy and safety of blue-light scleral cross-linking. J Refract Surg (2008) 0.84
Diameter of retinal vessels in patients with diabetic macular edema is not altered by intravitreal ranibizumab (lucentis). Retina (2014) 0.84
The effect of age on optic nerve head blood flow. Invest Ophthalmol Vis Sci (2005) 0.83
Diabetes mellitus affects biomechanical properties of the optic nerve head in the rat. Ophthalmic Res (2011) 0.83
Visual function and perfusion of the optic nerve head after application of centrally acting calcium-channel blockers. Graefes Arch Clin Exp Ophthalmol (2002) 0.82
Biomechanical significance of the human internal limiting lamina. Retina (2006) 0.82
Measurement of corneal changes after collagen crosslinking using a noninvasive ultrasound system. J Cataract Refract Surg (2010) 0.82
The relationship between central corneal thickness and optic disc size in patients with primary open-angle glaucoma in a hospital-based population. Acta Ophthalmol (2009) 0.81
Age-dependent correction factors for goldmann tonometry. J Glaucoma (2012) 0.79
First proposed efficacy study of high versus standard irradiance and fractionated riboflavin/ultraviolet a cross-linking with equivalent energy exposure. Eye Contact Lens (2014) 0.79
Influence of high-dose cortisol on the biomechanics of incubated porcine corneal strips. J Refract Surg (2009) 0.79
Contact lens dynamometry: the influence of age. Invest Ophthalmol Vis Sci (2010) 0.78
The effect of low-density lipoprotein apheresis on ocular microcirculation in patients with hypercholesterolaemia: a pilot study. Br J Ophthalmol (2010) 0.78
Short posterior ciliary artery, central retinal artery, and choroidal hemodynamics in brimonidine-treated primary open-angle glaucoma patients. Am J Ophthalmol (2003) 0.78
Influence of indocyanine green staining on the biomechanical properties of porcine anterior lens capsule. Curr Eye Res (2004) 0.78
Effect of the blue filter intraocular lens on the progression of geographic atrophy. Eur J Ophthalmol (2014) 0.77
The short-term effect of flavonoid-rich dark chocolate on retinal vessel diameter in glaucoma patients and age-matched controls. Acta Ophthalmol (2014) 0.75
Biomechanical and morphological differences between the sclera canal ring and a peripheral sclera ring in the porcine eye. Ophthalmic Res (2011) 0.75
The effect of acetazolamide on different ocular vascular beds. Graefes Arch Clin Exp Ophthalmol (2012) 0.75
Reply: To PMID 25532633. J Cataract Refract Surg (2015) 0.75
A defined change of polarization axis is detected by variable corneal compensation of the GDxVCC. J Glaucoma (2008) 0.75
[Causes, symptoms and therapeutic methods for glaucoma]. Med Monatsschr Pharm (2004) 0.75
[Reversible Perimacular Retinopathy by Long-Time Interferon alpha Therapy]. Klin Monbl Augenheilkd (2004) 0.75
[Diagnostic and therapeutic problems in chronic progressive external ophthalmoplegia (CPEO)]. Klin Monbl Augenheilkd (2003) 0.75
Increased Hair Cortisol Concentrations in Patients With Progressive Keratoconus. J Refract Surg (2017) 0.75
Expression of the transcription factor Hes3 in the mouse and human ocular surface, and in pterygium. Int J Radiat Biol (2014) 0.75
Transepithelial Corneal Cross-linking Using an Enhanced Riboflavin Solution. J Refract Surg (2016) 0.75
Corneal Biomechanical Changes After Trabeculectomy and the Impact on Intraocular Pressure Measurement. J Glaucoma (2016) 0.75
Statins affect ocular microcirculation in patients with hypercholesterolaemia. Acta Ophthalmol (2011) 0.75
Comparison of normal- and high-tension glaucoma: nerve fiber layer and optic nerve head damage. Ophthalmologica (2013) 0.75
Characterization of Ocular Biomechanics in Pellucid Marginal Degeneration. Cornea (2016) 0.75